NURS 5334 Advanced Pharmacology for Nurse Practitioners Latest Update| A Comprehensive Exam Study Guide All Modules – A Complete Review of 400 Multichoice Questions and Answers from Past Exams| with Detailed Clinical Rationale| Pass Guaranteed| Already Gr

Are you preparing for your NURS 5334 Advanced Pharmacology for Nurse Practitioners exam? Look no further! This comprehensive, up-to-date study guide is your ultimate resource for mastering pharmacological concepts and passing your NP certification exam with flying colors. NURS 5334 Advanced Pharmacology for Nurse Practitioners Latest Update| A Comprehensive Exam Study Guide All Modules – A Complete Review of 400 Multichoice Questions and Answers from Past Exams| with Detailed Clinical Rationale| Pass Guaranteed| Already Graded A+ ________________________________________ Table of Contents Module 1: Foundations of Prescriptive Authority & Basic Principles (Questions 1-47, 201-220) • Prescriptive Authority and Legal Considerations • Drug Selection Factors and Prescription Writing • Medication Adherence and Patient Education • Pharmacokinetics: Absorption, Distribution, Metabolism, Excretion • Pharmacodynamics: Drug-Receptor Interactions • Drug-Drug and Drug-Food Interactions • Adverse Drug Reactions and Medication Errors • Pharmacogenomics and Individual Variation Module 2: Autonomic Nervous System Pharmacology (Questions 48-68, 221-240) • Cholinergic and Anticholinergic Drugs • Adrenergic Agonists and Antagonists Module 3: Central Nervous System Pharmacology (Questions 69-96, 241-260) • Parkinson's Disease and Alzheimer's Disease Treatments • Antiepileptic Drugs • Antipsychotics and Antidepressants • Anxiolytics, Sedatives, and ADHD Medications Module 4: Cardiovascular Pharmacology (Questions 97-117, 261-280) • Hypertension Management • Heart Failure and Digoxin • Valvular Heart Disease and Endocarditis Prophylaxis Module 5: Pulmonary Pharmacology (Questions 118-136, 281-300) • Asthma Management • COPD Management • Community-Acquired Pneumonia Module 6: Gastrointestinal and Renal Pharmacology (Questions 137-156, 301-320) • Peptic Ulcer Disease and GERD • Hepatitis and Liver Disease • Urinary Tract Infections and Renal Disorders Module 7: Endocrine Pharmacology (Questions 157-180, 321-350) • Diabetes Mellitus Management • Thyroid Disorders • Lipid Management • Obesity Management Module 8: Hematology, Infectious Disease, and Special Populations (Questions 181-200, 351-400) • Antimicrobial Agents and Resistance • Anemia Management • Pediatric and Geriatric Considerations • Pain Management and Opioids ________________________________________ MULTICHOICE MODULE 1: FOUNDATIONS OF PRESCRIPTIVE AUTHORITY & BASIC PRINCIPLES Chapter 1: Prescriptive Authority and Legal Considerations Question 1 What is prescriptive authority determined by? A. Federal law and DEA regulations B. State law and state nurse practice acts C. The FDA and CDC guidelines D. Hospital credentialing committees Answer: B. State law and state nurse practice acts Rationale: Prescriptive authority is determined by state law. The state board of nursing, state board of medicine, or state board of pharmacy may have jurisdiction depending on the state. The federal government controls drug regulation but has no control over prescriptive authority. ________________________________________ Question 2 Which of the following represents a component of full prescriptive authority for an advanced practice nurse? A. The right to prescribe only Schedule IV and V medications B. The right to prescribe independently without physician supervision or collaboration C. The right to prescribe only non-controlled substances D. The right to prescribe only with physician co-signature Answer: B. The right to prescribe independently without physician supervision or collaboration Rationale: Full prescriptive authority includes the right to prescribe independently (not subject to rules requiring physician supervision or collaboration) and the right to prescribe without limitation (may prescribe any drugs, including controlled substances, with the exception of Schedule I drugs). ________________________________________ Question 3 Texas is described as a restricted state for prescriptive authority. Which barrier does this create for APRNs? A. APRNs cannot prescribe any controlled substances B. Restrictions may prevent outreach to areas with the greatest need C. APRNs must obtain a separate federal license to prescribe D. APRNs can only prescribe generic medications Answer: B. Restrictions may prevent outreach to areas with the greatest need Rationale: Limited prescriptive authority creates barriers to quality, affordable, and accessible patient care. Restrictions on the distance of the APRN from the physician providing supervision or collaboration may prevent outreach to underserved areas. A requirement to obtain physician co-signature on prescriptions can increase patient waits. ________________________________________ Question 4 What is the estimated physician shortage projected by 2025? A. 10,000 to 20,000 physicians B. 46,100 to 90,400 physicians C. 100,000 to 150,000 physicians D. 5,000 to 10,000 physicians Answer: B. 46,100 to 90,400 physicians Rationale: It is estimated that by 2025, the physician shortage will be between 46,100 to 90,400. In primary care alone, a 12,500 to 31,100 physician shortage is anticipated. APRNs with full prescriptive authority would help offset this shortage. ________________________________________ Chapter 2: Drug Selection Factors and Prescription Writing Question 5 When writing a prescription, which of the following is NOT a required key element? A. Patient's diagnosis code B. Prescriber's name and license number C. Medication strength and dosing frequency D. Patient's date of birth Answer: A. Patient's diagnosis code Rationale: Required prescription elements include prescriber name, license number, and contact information; DEA number (if applicable); patient name and date of birth; patient allergies; medication name, indication, strength, dosing frequency; number of tablets/capsules to dispense; and number of refills. The diagnosis code is not a required element on the prescription itself. ________________________________________ Question 6 Abbreviations on prescriptions are: A. Acceptable if commonly used B. No longer acceptable; everything should be written out C. Acceptable only for controlled substances D. Required for efficiency Answer: B. No longer acceptable; everything should be written out Rationale: Abbreviations are no longer acceptable. Everything should be written out to prevent medication errors. Example: "25 milligrams once daily by mouth for hypertension" instead of "25 mg PO QD." ________________________________________ Question 7 Which type of prescription CANNOT be prescribed or refilled by telephone? A. Schedule III medications B. Schedule IV medications C. Schedule II medications D. Schedule V medications Answer: C. Schedule II medications Rationale: Schedule II medications cannot be prescribed or refilled by phone. They require a written prescription or electronic prescription with proper authentication. ________________________________________ Question 8 When considering drug selection, which factor is most important to consider? A. The provider's preference B. Cost, guidelines, allergies, liver and renal function, and need for monitoring C. The most expensive medication available D. The newest medication on the market Answer: B. Cost, guidelines, allergies, liver and renal function, and need for monitoring Rationale: Many factors are involved in drug selection including cost, guidelines, liability interactions, side effects, allergies, liver and renal function, need for monitoring, and special populations. ________________________________________ Chapter 3: Medication Adherence and Patient Education Question 9 Medication adherence costs the United States approximately how much annually? A. $100 billion B. $290 billion C. $500 billion D. $50 billion Answer: B. $290 billion Rationale: Medication adherence costs the United States about $290 billion a year. It is often directly responsible for disease exacerbations, hospitalizations, transitioning to long-term care, and premature deaths. ________________________________________ Question 10 Which of the following is the biggest reason for medication non-adherence? A. Forgetfulness B. Cost C. Lack of planning D. Dissatisfaction Answer: B. Cost Rationale: Cost is one of the biggest reasons for non-adherence. Many patients cannot afford the medications prescribed. Pharmacies now have medications in individual packets with the date, day of the week, and time of day to help patients remember their medications. ________________________________________ Question 11 Which of the following is NOT a basic component of patient education for a new medication? A. Medication name (generic vs. trade) B. Purpose and desired effect C. Cost comparison with other pharmacies D. Side effects and how to manage them Answer: C. Cost comparison with other pharmacies Rationale: Basic components of education include: medication name (generic vs. trade); purpose (reason for taking and desired effect); dosing regimen (how much, how often, time of day); administration (preparation, with/without food); side effects (all risks and how to manage them); special storage needs; associated lab testing; food or drug interactions; and duration of therapy. ________________________________________ Question 12 The Patient Protection and Affordable Care Act of 2010 defines health literacy as: A. The ability to read prescription labels B. The degree to which an individual has the capacity to obtain, communicate, process, and understand basic health information and services C. The ability to afford healthcare services D. The knowledge of medical terminology Answer: B. The degree to which an individual has the capacity to obtain, communicate, process, and understand basic health information and services Rationale: Title V of the Patient Protection and Affordable Care Act of 2010 defines health literacy as "the degree to which an individual has the capacity to obtain, communicate, process, and understand basic health information and services to make appropriate health decisions." ________________________________________ Chapter 4: Pharmacokinetics: Absorption, Distribution, Metabolism, Excretion Question 13